Cocrystal Pharma to Present at Noble Capital Markets Emerging Growth Virtual Equity Conference

Company Overview - Cocrystal Pharma, Inc. is a clinical-stage biotechnology company focused on developing innovative antiviral treatments for diseases such as influenza, viral gastroenteritis, COVID, and hepatitis [4] - The company utilizes unique structure-based technologies and Nobel Prize-winning expertise to create first- and best-in-class antiviral drugs [4] Upcoming Event - James Martin, CFO and co-CEO of Cocrystal, will present a company overview at the Noble Capital Markets Emerging Growth Virtual Equity Conference on October 9, 2025, at 12:00 pm Eastern time [1] - The presentation will include a question-and-answer session with the live virtual audience [1] Investor Engagement - A video webcast of the presentation will be available within 48 hours after the event and archived for 90 days on the company's website [2] - Mr. Martin will be available for virtual one-on-one meetings with registered, qualified investors throughout the conference [2]